These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2990961)

  • 1. A specific alkylating ligand for phencyclidine (PCP) receptors antagonizes PCP behavioral effects.
    Contreras PC; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
    Eur J Pharmacol; 1985 May; 111(3):405-6. PubMed ID: 2990961
    [No Abstract]   [Full Text] [Related]  

  • 2. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat.
    Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine-like effects of tetrahydroisoquinolines and related compounds.
    Gray NM; Cheng BK; Mick SJ; Lair CM; Contreras PC
    J Med Chem; 1989 Jun; 32(6):1242-8. PubMed ID: 2542555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonistic and antagonistic effects of PCP-derivatives and sigma opioids in PCP behavioral and receptor assays.
    Contreras PC; Quirion R; O'Donohue TL
    NIDA Res Monogr; 1986; 64():80-93. PubMed ID: 3012347
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of metaphit on phencyclidine and serotonin2 receptors.
    Nabeshima T; Tohyama K; Noda A; Maeda Y; Hiramatsu M; Harrer SM; Kameyama T; Furukawa H; Jacobson AE; Rice KC
    Neurosci Lett; 1989 Jul; 102(2-3):303-8. PubMed ID: 2554211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metaphit, a proposed phencyclidine receptor acylator: phencyclidine-like behavioral effects and evidence of absence of antagonist activity in pigeons and in rhesus monkeys.
    Koek W; Woods JH; Jacobson AE; Rice KC; Lessor RA
    J Pharmacol Exp Ther; 1986 May; 237(2):386-92. PubMed ID: 3009781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and behavioral effects of sigma and PCP ligands.
    Contreras PC; Contreras ML; O'Donohue TL; Lair CC
    Synapse; 1988; 2(3):240-3. PubMed ID: 2850629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophilic affinity ligands for the phencyclidine (PCP) receptor.
    Lessor RA; Mattson MV; Rice KC; Jacobson AE
    NIDA Res Monogr; 1986; 67():138-44. PubMed ID: 3018571
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic properties of some phencyclidine analogs in rats.
    Cho AK; Hiramatsu M; Schmitz DA; Nabeshima T; Kameyama T
    Pharmacol Biochem Behav; 1991 Aug; 39(4):947-53. PubMed ID: 1837152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral pharmacology of PCP, NMDA and sigma receptors.
    Balster RL
    NIDA Res Monogr; 1989; 95():270-4. PubMed ID: 2561831
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat.
    Sturgeon RD; Fessler RG; London SF; Meltzer HY
    Eur J Pharmacol; 1981 Nov; 76(1):37-53. PubMed ID: 6119221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metaphit, a proposed phencyclidine (PCP) antagonist, prevents PCP-induced locomotor behavior through mechanisms unrelated to specific blockade of PCP receptors.
    French ED; Jacobson AE; Rice KC
    Eur J Pharmacol; 1987 Aug; 140(3):267-74. PubMed ID: 2820762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions.
    Contreras PC; Rice KC; Jacobson AE; O'Donohue TL
    Eur J Pharmacol; 1986 Feb; 121(1):9-18. PubMed ID: 3007170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat.
    Mattia A; Marquis KL; Leccese AP; el-Fakahany EE; Moreton JE
    J Pharmacol Exp Ther; 1988 Aug; 246(2):797-802. PubMed ID: 2841454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroencephalographic (EEG), psychopharmacological, and receptor-binding profiles of 'phencyclinoids'.
    Mattia A; Leccese AP; Marquis KL; el-Fakahany EE; Moreton JE
    NIDA Res Monogr; 1986; 64():94-111. PubMed ID: 3012348
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of phencyclidine analogs and phencyclidine/sigma ligands on vasoconstrictor response of rat mesenteric arteries induced by electrical field stimulation].
    Lu YF; Sun FY; Zhang AZ
    Zhongguo Yao Li Xue Bao; 1990 Jul; 11(4):293-5. PubMed ID: 1966572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol antagonizes phencyclidine-induced hyperactivity and stereotypy in rats.
    Consroe P; Boren JL; Hsu CH
    Pharmacology; 1982; 24(2):96-104. PubMed ID: 7200612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
    Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral and receptor binding studies of phencyclidine (PCP) and lithium interaction in the rat.
    Mattia A; el-Fakahany EE; Moreton JE
    Life Sci; 1986 Mar; 38(11):975-84. PubMed ID: 3005791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of hippocampal phencyclidine (PCP) receptors following amygdala kindling.
    Sircar R; Ludvig N; Zukin SR; Moshé SL
    Eur J Pharmacol; 1987 Sep; 141(1):167-8. PubMed ID: 2822446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.